المؤلفون: Liu H; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China; School of Basic Medical Sciences, International Cancer Institute, Peking University, Beijing 100191, China., Gao J; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China; Institute of Photomedicine and Department of Phototherapy at Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China., Feng M; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China., Cheng J; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China., Tang Y; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Cao Q; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China., Zhao Z; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China., Meng Z; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China., Zhang J; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Zhang G; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Zhang C; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Zhao M; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Yan Y; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Wang Y; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China., Xue R; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China; School of Basic Medical Sciences, International Cancer Institute, Peking University, Beijing 100191, China. Electronic address: rxue@hsc.pku.edu.cn., Zhang N; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China; School of Basic Medical Sciences, International Cancer Institute, Peking University, Beijing 100191, China; Yunnan Baiyao Group, Kunming 650500, China. Electronic address: zhangning@bjmu.edu.cn., Li H; Peking University-Yunnan Baiyao International Medical Research Center, Peking University First Hospital, Beijing 100191, China; National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University First Hospital, Beijing 100034, China; Yunnan Baiyao Group, Kunming 650500, China. Electronic address: drlihang@126.com.

المصدر: Cancer cell [Cancer Cell] 2024 Jun 10; Vol. 42 (6), pp. 1067-1085.e11. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/genetics , Melanoma*/immunology , Melanoma*/pathology , Epithelial-Mesenchymal Transition*/genetics , Skin Neoplasms*/genetics , Skin Neoplasms*/immunology , Skin Neoplasms*/pathology , Antigens, Differentiation, Myelomonocytic*/metabolism , Antigens, Differentiation, Myelomonocytic*/genetics , Antigens, CD*/metabolism , Antigens, CD*/genetics , Neoplasm Invasiveness*, Humans ; Apolipoproteins E/genetics ; Macrophages/immunology ; Macrophages/metabolism ; Male ; Female ; Receptor, IGF Type 1/genetics ; Receptor, IGF Type 1/metabolism ; Tumor Microenvironment/immunology ; Tumor Microenvironment/genetics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic ; Spatial Analysis ; Middle Aged ; Prognosis ; Disease Progression ; Aged ; Receptors, Cell Surface

المؤلفون: Peng R; Department of Dermatology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Zhang G; Division of Pathology, Shantou University Medical College, Shantou, Guangdong., Li H; Department of Dermatology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.

المصدر: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2023 May 01; Vol. 49 (5S), pp. S27-S33. Date of Electronic Publication: 2023 Mar 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9504371 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4725 (Electronic) Linking ISSN: 10760512 NLM ISO Abbreviation: Dermatol Surg Subsets: MEDLINE

مواضيع طبية MeSH: Dermatofibrosarcoma*/diagnosis , Dermatofibrosarcoma*/genetics , Dermatofibrosarcoma*/pathology , Skin Neoplasms*/pathology, Humans ; Proto-Oncogene Proteins c-sis/genetics ; Proto-Oncogene Proteins c-sis/metabolism ; Transcriptome ; RNA-Seq ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism

المؤلفون: Yan Y; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Tian J; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; Institute of Medical Technology, Peking University Health Science Center, Beijing, China., Wang Y; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Li Y; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Zhang C; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Zhang S; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Lin P; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Peng R; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Zhao C; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China., Zhuang L; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; Department of Dermatology, Qilu Hospital of Shandong University, Jinan, China., Lai B; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; Institute of Medical Technology, Peking University Health Science Center, Beijing, China; Department of Biomedical Engineering, College of Engineering, Peking University, Beijing, China., Zhou L; National Institute of Health Data Science, Peking University, Beijing, China., Zhang G; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; Pathology Department, Shantou University Medical College, Guangdong, China., Li H; Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China. Electronic address: drlihang@126.com.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2023 Mar; Vol. 143 (3), pp. 398-407.e5. Date of Electronic Publication: 2022 Sep 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Transcriptome* , Skin Neoplasms*/metabolism, Humans ; Skin/metabolism ; Gene Expression Profiling ; Gene Expression Regulation

المؤلفون: Lin P; Department of Dermatology and Venereology, Peking University First Hospital.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses.; National Clinical Research Center for Skin and Immune Diseases., Zhu S; Department of Biostatistics, Peking University First Hospital, Beijing., Zhang G; Department of Pathology, Shantou University Medical College, Shantou, Guangdong, China., Huang Y; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada., Tu P; Department of Dermatology and Venereology, Peking University First Hospital.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses.; National Clinical Research Center for Skin and Immune Diseases., Yang S; Department of Dermatology and Venereology, Peking University First Hospital.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses.; National Clinical Research Center for Skin and Immune Diseases., Li H; Department of Dermatology and Venereology, Peking University First Hospital.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses.; National Clinical Research Center for Skin and Immune Diseases.

المصدر: Medicine [Medicine (Baltimore)] 2021 Feb 19; Vol. 100 (7), pp. e24767.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Margins of Excision* , Nomograms*, Carcinoma, Squamous Cell/*surgery , Mohs Surgery/*methods , Skin Neoplasms/*surgery, Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/pathology ; Case-Control Studies ; China ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies ; Risk Factors ; Skin Neoplasms/pathology

المؤلفون: Zhang G; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology, Shantou University Medical College, Shantou, Guangdong, China., Cheng Y; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Chen G; Bioelectromagnetics Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China., Tang Y; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Ardekani G; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Rotte A; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Martinka M; Department of Pathology, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., McElwee K; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Xu X; Department of Dermatology, 2nd Affiliated Hospital, Dalian Medical University, Dalian, China., Wang Q; Department of Dermatology, 2nd Affiliated Hospital, Dalian Medical University, Dalian, China., Zhou Y; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Dermatology, 2nd Affiliated Hospital, Dalian Medical University, Dalian, China.; Dermatologic Oncology Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

المصدر: Oncotarget [Oncotarget] 2015 Sep 08; Vol. 6 (26), pp. 23026-35.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Cyclin-Dependent Kinase Inhibitor p27/*deficiency , Kangai-1 Protein/*deficiency , Melanoma/*classification , Melanoma/*metabolism , Skin Neoplasms/*genetics, Biomarkers, Tumor/deficiency ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cyclin-Dependent Kinase Inhibitor p27/genetics ; Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Female ; Humans ; Kangai-1 Protein/genetics ; Kangai-1 Protein/metabolism ; Male ; Melanoma/genetics ; Melanoma/pathology ; Middle Aged ; Prognosis ; Skin Neoplasms/pathology ; Melanoma, Cutaneous Malignant

المؤلفون: Lu J; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z IL8, Canada., Cheng Y; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z IL8, Canada., Zhang G; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z IL8, Canada., Tang Y; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z IL8, Canada., Dong Z; Department of Pathophysiology, Basic Medical College, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China., McElwee KJ; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z IL8, Canada., Li G; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z IL8, Canada.

المصدر: Molecular medicine reports [Mol Med Rep] 2015 Aug; Vol. 12 (2), pp. 2668-76. Date of Electronic Publication: 2015 May 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-3004 (Electronic) Linking ISSN: 17912997 NLM ISO Abbreviation: Mol Med Rep Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma/*diagnosis , Neuropilin-1/*analysis , Skin/*pathology , Skin Neoplasms/*diagnosis, Biomarkers, Tumor/analysis ; Biomarkers, Tumor/biosynthesis ; Disease Progression ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Matrix Metalloproteinase 2/analysis ; Melanoma/pathology ; Middle Aged ; Prognosis ; Skin Neoplasms/pathology ; Tissue Array Analysis ; Up-Regulation

المؤلفون: Cheng Y; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Lu J; Department of Pathophysiology, Basic Medical College, Zhengzhou University, Zhengzhou, Henan, China., Chen G; Bioelectromagnetics Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China., Ardekani GS; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Rotte A; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Martinka M; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada., Xu X; Department of Dermatology, Second Affiliated Hospital, Dalian Medical University, Dalian, China., McElwee KJ; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Zhang G; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology, Shantou University Medical College, Shantou, Guangdong, China., Zhou Y; Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

المصدر: Oncotarget [Oncotarget] 2015 Feb 28; Vol. 6 (6), pp. 4180-9.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Melanoma/*metabolism , Melanoma/*pathology , Skin Neoplasms/*metabolism , Skin Neoplasms/*pathology, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Disease Progression ; Female ; Humans ; Male ; Matrix Metalloproteinase 2/metabolism ; Middle Aged ; Neoplasm Staging ; Prognosis ; Proto-Oncogene Proteins B-raf/metabolism ; Young Adult

المؤلفون: Lu J; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada., Zhang G; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada., Cheng Y; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada., Tang Y; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada., Dong Z; Department of Pathophysiology, Basic Medical College, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China., McElwee KJ; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada., Li G; Department of Dermatology and Skin Science, Research Pavilion, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada.

المصدر: Oncology reports [Oncol Rep] 2014 Dec; Vol. 32 (6), pp. 2571-9. Date of Electronic Publication: 2014 Oct 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma/*metabolism , SOXF Transcription Factors/*metabolism , Skin Neoplasms/*metabolism, Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Tissue Array Analysis ; Tumor Burden

المؤلفون: Bhandaru M, Ardekani GS, Zhang G, Martinka M, McElwee KJ, Li G, Rotte A; Skin Cancer Biology Laboratory, Department of Dermatology and Skin Science, University of British Columbia, Research Pavilion, 828 West, 10th Avenue, Vancouver, BC V5Z 1 L8, Canada. anand.rotte@gmail.com.

المصدر: BMC cancer [BMC Cancer] 2014 Jun 03; Vol. 14, pp. 398. Date of Electronic Publication: 2014 Jun 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: E1A-Associated p300 Protein/*biosynthesis , Melanoma/*genetics , Proto-Oncogene Proteins B-raf/*biosynthesis , Skin Neoplasms/*genetics, Adult ; Aged ; Biomarkers, Tumor/biosynthesis ; Disease Progression ; Female ; Humans ; Indoles/administration & dosage ; Kaplan-Meier Estimate ; Male ; Melanoma/drug therapy ; Melanoma/pathology ; Prognosis ; Proportional Hazards Models ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Sulfonamides/administration & dosage ; Vemurafenib